New patent legislation introduced in US, offers industry “greater predictability”
This article was originally published in Clinica
US Senator John Kyl has introduced a new patent reform bill, the Patent Reform Act (S3600), into the Senate this week after previous proposals for reforming the system raised strong objections from medtech and pharmaceutical companies. The new bill has been welcomed by the healthcare industry as a vast improvement on the legislative proposals currently pending in the House and Senate.
You may also be interested in...
The US healthcare reform proposals signed into law on 23 March include requirements on medical device companies to reveal payments or gifts they make to doctors. Peter Rixon takes a closer look at what the reforms’ “sunshine” provisions actually mean
Compliance, approvals, inspections and many other burning issues will be on the agenda of a US conference that takes place in early May.
Compliance, approvals, inspections and many other burning issues will be on the agenda of a US conference that takes place in the coming weeks.